MedPath

Genetic Study of the Dilatations of the Idiopathic Bronchi in French Polynesia

Completed
Conditions
Idiopathic Bronchiectasis
Interventions
Genetic: Blood Test
Registration Number
NCT04417777
Lead Sponsor
Centre Hospitalier Intercommunal Creteil
Brief Summary

Bronchiectasis, defined by an increase in bronchial caliber and thickening of the bronchial wall, is associated with recurrent respiratory infections, chronic cough and bronchorrhea, and a frequent progression to chronic respiratory failure. Investigator distinguish focal bronchiectasis usually resulting from a localized cause and diffuse bronchiectasis which the possible causes are multiple (immune deficiencies, genetic diseases, auto immune pathologies, aspergillosis broncho -allergic lung, sequelae of pulmonary infections).The etiological assessment is negative in 26 to 53% of cases, defining the idiopathic bronchiectasis. However, the discovery of an underlying cause can change the patient's management (up to 37% of cases).

Despite the lack of epidemiological data in French Polynesia, Australian and New Zealand studies found a high prevalence of bronchiectasis in Polynesians. Few clinical studies published in the early 1980s suggested a ciliary origin.

Due to its geographic characteristics, the Polynesian population constitutes an interesting ethnic group. Indeed, there is a low genetic mixing and the prevalence of certain genetic diseases like the syndrome of Alport or some hereditary retinal dystrophies are high. This type of population is very suitable for discovering new genes in human pathology.

Investigator decided to conduct an observational study to find an underlying genetic cause of bronchiectasis in Polynesians by performing a whole exome sequencing. Investigator chose to study index cases defined by an upset of symptoms during the childhood, a family history of idiopathic bronchiectasis, and/or a consanguinity. Investigator also want to study healthy first degree relatives, in order to be able to better identify the clinical significant of DNA variants and focus the analysis on those that may be pathogenic

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Polynesian adult more than18 years
  • dilatation of idiopathic bronchi confirmed to thoracic CTscan
  • Negative etiological balance (including sweat test, research of Dyskinesia Ciliary Primitive and immunological check-up)
  • Appearance of symptoms in childhood, or family history of chronic bronchial disease, or notion of inbreeding
  • Signed consent
  • Affiliated with a social security system
Exclusion Criteria
  • Refusal to participate in the study

    *Relatives

  • First-degree healthy relatives

  • Polynesian adult more than 18 years

  • Signed consent

  • Affiliated with a social security system

Exclusion Criteria:

  • Refusal to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Polynesian patientBlood TestPatient with dilatation of idiopathic bronchi
Relatives of polynesian patientBlood TestHealthy
Primary Outcome Measures
NameTimeMethod
identification of genetic mutationAnytime in the period of 10 years

New mutation in the coding region or mutation located outside the coding regions on the transcriptome

Secondary Outcome Measures
NameTimeMethod
scannographic descriptionAnytime in the period of 10 years

Extra-respiratory history Bronchial colonizations Scannographic aspect

Effect on the splicing of messenger RNAAnytime in the period of 10 years

correlation genotype/phenotype

transcriptome of patientsAnytime in the period of 10 years

correlation genotype/phenotype

Clinical phenotypeAnytime in the period of 10 years

Extra-respiratory history Bronchial colonizations Scannographic aspect

Trial Locations

Locations (1)

CH Polynesie Française

🇵🇫

Papeete, French Polynesia

© Copyright 2025. All Rights Reserved by MedPath